What we’re reading, October 26, 2016: AAP advises that parents take measures to reduce the risk of SIDS; Republican presidential nominee Donald Trump reacts to ACA premium hikes announced by HHS; patients with ALS volunteer for an accelerated study on the effects of a dietary supplement.
The American Academy of Pediatrics (AAP) has issued an updated set of guidelines meant to lower the risk of sudden infant death syndrome (SIDS). It specifies that infants should ideally sleep in the same room as their parents for the first 6 to 12 months of their lives, but they should sleep in their own crib with only a fitted sheet on the mattress. The report also cautions that exhausted parents can often fall asleep on a couch or rocking chair after feeding the baby, which poses a high risk of suffocation.
The announcement that Affordable Care Act (ACA) premiums will rise an average of 22% in 2017 drew criticism from Republican presidential nominee Donald Trump during a speech in which he seemingly contradicted himself regarding his employees’ health insurance. After proclaiming that “all of [his] employees are having a tremendous problem with Obamacare,” he later said that they “don’t even use Obamacare. We don’t want it.” Trump has repeatedly called to repeal the ACA and replace it with something “much less expensive.”
50 patients with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease) have volunteered to take part in a streamlined study to test the potential effects of the dietary supplement lunacin. The protocols for this study, which does not include a control group receiving a placebo, are considerably less rigorous than those of a traditional clinical trial because the researchers want to quickly observe any promising effects the supplement may have. Participants are likewise enthusiastic about the accelerated pace of the trial and their ability to easily report their symptoms online.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More